Lambert, B. L., Cunningham, F. E, Miller, D. R., Dalack, G. W., & Hur, K. (2006). Diabetes risk associated with use of olanzapine, quetiapine and risperidone in VA patients with schizophrenia. American Journal of Epidemiology, 164, 672-681 . [view .pdf]
Lin, S.-J., Lambert, B., Tan, H., & Toh, S. (in press). Frequency estimates from prescription drug datasets. Pharmacoepidemiology and Drug Safety, 15, 512-520 . [view .pdf]
Viswanathan, H. & Lambert, B. L. (2005). An inquiry into medication meanings, illness, medication use, and the transformative potential of chronic illness among African Americans with hypertension. Research in Social and Administrative Pharmacy, 1, 21-39. [view .pdf]
Lambert, B. L., Chou, C.-H., Chang, K.-Y., Tafesse, E., & Carson, W. (2005). Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: A matched case-control study of California Medicaid claims. Journal of Pharmacoepidemiology and Drug Safety,14, 417-425. [view .pdf]
Lambert, B. L., Lin, S.-J., & Tan, H. K. (2005). Designing safe drug names. Drug Safety, 28, 495-512. [view .pdf]
Lambert, B. L., Chang, K.-Y., Tafesse, E., & Carson, W. (2005). Association between antipsychotic treatment and hyperlipidemia among California Medicaid patients with schizophrenia. Journal of Clinical Psychopharmacology, 25, 12-18. [view .pdf]
Bonito, J. A., & Lambert, B. L. (2005) Information similarity is a moderator on the effect of gender on participation in small groups: A multilevel analysis. Small Group Research, 36, 139-165.
Lambert, B. L., Yu, C., Thirumulai, M. (2004). A system for multiattribute drug product comparison. Journal of Medical Systems, 28(1), 29-54. [view .pdf]
Lambert, B. L., Chang, K.-Y., Gupta, P. (2003). Effects of frequency and similarity neighborhoods on pharmacists’ visual perception of drug names. Social Science & Medicine, 57, 1939-1955. [view .pdf]
Lambert, B. L. Chang, K.-Y., & Lin, S.-J. (2003). Immediate free recall of drug names: Effects of similarity and availability. American Journal of Health-System Pharmacy, 60, 156-168. [view .pdf]
Lambert, B. L., Donderi, D., & Senders, J. (2002). Similarity of drug names: Objective and subjective measures. Psychology & Marketing, 19 (7-8), 641-661. [view .pdf]
Brewer, W. F., & Lambert, B. L. (2001). The theory-ladenness of observation and the theory-ladenness of the rest of the scientific process. Philosophy of Science, 68 (3), S176-S186. [view .pdf]
Gandhi, S. K., Salmon, J. W., Zhao, S. Z., Lambert, B. L., Gore, P. R., Conrad, K. (2001). Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials. Clinical Therapeutics, 23 (7), 1080-1098. [view .pdf]
Lambert, B. L. Chang, K.-Y., & Lin, S.-J. (2001). Effect of orthographic and phonological similarity on false recognition of drug names. Social Science & Medicine, 52, 1843-1857. [view .pdf]
Lambert, B. L., Chang, K.-Y., Lin, S.-J. (2001). Descriptive analysis of the drug name lexicon. Drug Information Journal, 35, 163-172. [view .pdf]
Lambert, B. L., Butin, D. N., Moran, D., Zhao, S. Z., Carr, B. C., Chen, C., Kizis, F. J. (2000). Arthritis care: Comparison of physicians’ and patients’ views. Seminars in Arthritis and Rheumatism, 30 (2), 100-110. [view .pdf]
Lambert, B. L., Lin, S.-J., Chang, K.-Y., & Gandhi, S. K. (1999). Similarity as a risk factor in drug name confusion errors: The look-alike (orthographic) and sound-alike (phonetic) model. Medical Care, 37(12), 1214-1225. [view .pdf]
Lambert, B. L. (1998). Pharmacist-physician communication. International Pharmacy, 12, 53-56. [view .pdf]
Lambert, B. L., Salmon, J. W., Stubbings, J., Gilomen-Study, G., Valuck, R., & Kezlarian, K. (1997). Factors associated with antibiotic prescribing in a managed care setting: An exploratory investigation. Social Science & Medicine, 45, 1767-1779. [view .pdf]
Lewis, R. K., Lasack, N. L., Lambert, B. L., & Connor, S. (1997). Patient counseling: A focus on maintenance therapy. American Journal of Health-System Pharmacy, 54, 2084-2098.
Lambert, B. L. (1997). Predicting look-alike and sound-alike medication errors. American Journal of Health-System Pharmacy, 54, 1161-1171. [view .pdf]
Lambert, B. L., Street, R. Jr., Cegala, D., Smith, D., Kurtz, S., & Schofield, T. (1997). Provider-patient communication, patient-centered care, and the mangle of practice. Health Communication, 9, 27-43. [view .pdf]
Lambert, B. L. (1996). Face and politeness in pharmacist-physician interaction. Social Science & Medicine, 43(8), 1189-1198. [view .pdf]
Luo, A. Y., Salmon, J. W., Lambert, B. L. (1996). U.S. pharmaceutical firm prospects within the People’s Republic of China. Journal of Managed Care Pharmacy, 2, 76-81.
Lambert, B. L. (1995). Directness and deference in pharmacy students’ messages to physicians. Social Science & Medicine, 40(4), 545-555. [view .pdf]
Lambert, B. L., & Gillespie, J. L. (1994). Patient perceptions of pharmacy students’ hypertension compliance gaining messages: Effects of message design logic and content themes. Health Communication, 6(4), 311-325. [view .pdf]
Hammond, S. L., & Lambert, B. L. (1994). Communicating about medications: Directions for research. Health Communication, 6(4), 247-251. [view .pdf]
Hammond, S. L., & Lambert, B. L. (Eds.). (1994). Communicating with patients about their medications [Special issue]. Health Communication, 6(4).